Becker's Healthcare March 19, 2025
Alexandra Murphy

Purdue Pharma has submitted a revised Chapter 11 bankruptcy plan proposing more than $7.4 billion in cash payments to creditors, including U.S. states and others, to compensate victims of the opioid crisis, Bloomberg reported March 18.

The plan includes the dissolution of Purdue and the creation of a new public benefit company, which will operate independently of the company’s current owners, the Sackler family.

Under the proposal, the Sacklers would contribute up to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Pharma Dodges The Tariff Bullet — But For How Long?
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs
How BioPharma Can Improve Consumers’ Experience and Health
The Go-To Law Firms For Healthcare and Life Sciences

Share This Article